• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与阿霉素的作用相比,两种二聚体核糖核酸酶对甲状腺癌细胞具有高度选择性的毒性和促凋亡作用。

Highly selective toxic and proapoptotic effects of two dimeric ribonucleases on thyroid cancer cells compared to the effects of doxorubicin.

作者信息

Spalletti-Cernia D, Sorrentino R, Di Gaetano S, Piccoli R, Santoro M, D'Alessio G, Laccetti P, Vecchio G

机构信息

Istituto di Endocrinologia ed Oncologia Sperimentale del CNR c/o Dipartimento di Biologia e Patologia Cellulare e Molecolare, Università di Napoli Federico II, via S. Pansini 5, 80131 Naples, Italy.

出版信息

Br J Cancer. 2004 Jan 12;90(1):270-7. doi: 10.1038/sj.bjc.6601491.

DOI:10.1038/sj.bjc.6601491
PMID:14710239
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2395318/
Abstract

The lack of selectivity of conventional antitumour drugs against cancer cells is responsible for their high toxicity. The development of new tumour-specific drugs is therefore highly needed. We tested the cytotoxic effects and the nature of cell death induced by a naturally dimeric bovine RNase and a newly engineered dimeric human RNase upon three genetically well-defined normal and malignant thyroid cell systems. RNases effects were compared with those of doxorubicin, a conventional antineoplastic drug. Our results show significant and selective proapoptotic effects exerted on tumour cells by both RNases, the strength of their cytotoxic and apoptotic activity being directly related to the degree of cell malignancy. No toxic effects were observed upon normal cells. Doxorubicin showed, instead, cytotoxic and apoptotic effects also against normal cells. The in vitro results were corroborated by the antitumour action of both dimeric RNases towards a malignant human thyroid tumour grown in nude mice. These results indicate a selective action of dimeric RNases against cancer cells and suggest the potential application of these molecules or their derivatives to the treatment of aggressive subtypes of thyroid cancer.

摘要

传统抗肿瘤药物对癌细胞缺乏选择性,这导致了它们的高毒性。因此,迫切需要开发新的肿瘤特异性药物。我们测试了一种天然二聚体牛核糖核酸酶和一种新设计的二聚体人核糖核酸酶对三种基因明确的正常和恶性甲状腺细胞系统的细胞毒性作用以及诱导的细胞死亡性质。将核糖核酸酶的作用与传统抗肿瘤药物阿霉素的作用进行了比较。我们的结果表明,两种核糖核酸酶均对肿瘤细胞产生显著且选择性的促凋亡作用,其细胞毒性和凋亡活性的强度与细胞恶性程度直接相关。未观察到对正常细胞的毒性作用。相反,阿霉素对正常细胞也显示出细胞毒性和凋亡作用。二聚体核糖核酸酶对裸鼠体内生长的恶性人甲状腺肿瘤的抗肿瘤作用证实了体外实验结果。这些结果表明二聚体核糖核酸酶对癌细胞具有选择性作用,并提示这些分子或其衍生物在侵袭性甲状腺癌亚型治疗中的潜在应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6248/2395318/a2611035a817/90-6601491f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6248/2395318/2131e55268bf/90-6601491f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6248/2395318/6c6099e5d224/90-6601491f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6248/2395318/ea4512c2e9dd/90-6601491f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6248/2395318/a2611035a817/90-6601491f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6248/2395318/2131e55268bf/90-6601491f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6248/2395318/6c6099e5d224/90-6601491f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6248/2395318/ea4512c2e9dd/90-6601491f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6248/2395318/a2611035a817/90-6601491f4.jpg

相似文献

1
Highly selective toxic and proapoptotic effects of two dimeric ribonucleases on thyroid cancer cells compared to the effects of doxorubicin.与阿霉素的作用相比,两种二聚体核糖核酸酶对甲状腺癌细胞具有高度选择性的毒性和促凋亡作用。
Br J Cancer. 2004 Jan 12;90(1):270-7. doi: 10.1038/sj.bjc.6601491.
2
A dimeric mutant of human pancreatic ribonuclease with selective cytotoxicity toward malignant cells.一种对恶性细胞具有选择性细胞毒性的人胰腺核糖核酸酶二聚体突变体。
Proc Natl Acad Sci U S A. 1999 Jul 6;96(14):7768-73. doi: 10.1073/pnas.96.14.7768.
3
Antineoplastic ribonucleases selectively kill thyroid carcinoma cells via caspase-mediated induction of apoptosis.抗肿瘤核糖核酸酶通过半胱天冬酶介导的凋亡诱导选择性杀死甲状腺癌细胞。
J Clin Endocrinol Metab. 2003 Jun;88(6):2900-7. doi: 10.1210/jc.2002-020373.
4
In vivo and in vitro growth-inhibitory effect of bovine seminal ribonuclease on a system of rat thyroid epithelial transformed cells and tumors.
Cancer Res. 1992 Sep 1;52(17):4582-6.
5
Selective activity of BS-RNase against anaplastic thyroid cancer.BS-核糖核酸酶对间变性甲状腺癌的选择性活性。
Anticancer Res. 2001 Mar-Apr;21(2A):1035-42.
6
Second generation antitumour human RNase: significance of its structural and functional features for the mechanism of antitumour action.第二代抗肿瘤人核糖核酸酶:其结构和功能特征对抗肿瘤作用机制的意义
Biochem J. 2001 Aug 15;358(Pt 1):241-7. doi: 10.1042/0264-6021:3580241.
7
Bovine seminal ribonuclease selectively kills human multidrug-resistant neuroblastoma cells via induction of apoptosis.牛精核糖核酸酶通过诱导凋亡选择性杀死人多药耐药神经母细胞瘤细胞。
Int J Oncol. 1999 Nov;15(5):1001-9. doi: 10.3892/ijo.15.5.1001.
8
The role of electrostatic interactions in the antitumor activity of dimeric RNases.静电相互作用在二聚体核糖核酸酶抗肿瘤活性中的作用。
FEBS J. 2006 Aug;273(16):3687-97. doi: 10.1111/j.1742-4658.2006.05373.x.
9
On the track of antitumour ribonucleases.追踪抗肿瘤核糖核酸酶
Mol Biosyst. 2005 Oct;1(4):294-302. doi: 10.1039/b502847g. Epub 2005 Sep 22.
10
De novo ceramide synthesis is responsible for the anti-tumor properties of camptothecin and doxorubicin in follicular thyroid carcinoma.从头神经酰胺合成负责喜树碱和阿霉素在滤泡性甲状腺癌中的抗肿瘤特性。
Int J Biochem Cell Biol. 2009 May;41(5):1165-72. doi: 10.1016/j.biocel.2008.10.021. Epub 2008 Nov 5.

引用本文的文献

1
Anticancer Activity of Reconstituted Ribonuclease S-Decorated Artificial Viral Capsid.重组核糖核酸酶 S 修饰的人工病毒衣壳的抗癌活性。
Chembiochem. 2022 Aug 3;23(15):e202200220. doi: 10.1002/cbic.202200220. Epub 2022 Jun 21.
2
Biological Activities of Secretory RNases: Focus on Their Oligomerization to Design Antitumor Drugs.分泌型核糖核酸酶的生物学活性:聚焦于其寡聚化以设计抗肿瘤药物。
Front Immunol. 2019 Nov 26;10:2626. doi: 10.3389/fimmu.2019.02626. eCollection 2019.
3
Structural features for the mechanism of antitumor action of a dimeric human pancreatic ribonuclease variant.

本文引用的文献

1
Transformation by v-ras oncogene correlates with an increased drug-resistance in an epithelial thyroid-cell system.在甲状腺上皮细胞系统中,v-ras癌基因介导的转化与耐药性增加相关。
Int J Oncol. 1995 Mar;6(3):647-54. doi: 10.3892/ijo.6.3.647.
2
Antineoplastic ribonucleases selectively kill thyroid carcinoma cells via caspase-mediated induction of apoptosis.抗肿瘤核糖核酸酶通过半胱天冬酶介导的凋亡诱导选择性杀死甲状腺癌细胞。
J Clin Endocrinol Metab. 2003 Jun;88(6):2900-7. doi: 10.1210/jc.2002-020373.
3
High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma.
一种二聚体人胰腺核糖核酸酶变体抗肿瘤作用机制的结构特征
Protein Sci. 2009 Jan;18(1):50-7. doi: 10.1002/pro.6.
甲状腺癌中BRAF突变的高发生率:甲状腺乳头状癌中RET/PTC-RAS-BRAF信号通路组成性激活的遗传学证据。
Cancer Res. 2003 Apr 1;63(7):1454-7.
4
Ribonuclease inhibitor as an intracellular sentry.核糖核酸酶抑制剂作为一种细胞内哨兵。
Nucleic Acids Res. 2003 Feb 1;31(3):1024-32. doi: 10.1093/nar/gkg163.
5
Gene therapy of thyroid cancer via retrovirally-driven combined expression of human interleukin-2 and herpes simplex virus thymidine kinase.通过逆转录病毒驱动的人白细胞介素-2和单纯疱疹病毒胸苷激酶联合表达对甲状腺癌进行基因治疗。
Eur J Endocrinol. 2003 Jan;148(1):73-80. doi: 10.1530/eje.0.1480073.
6
ZD6474, an orally available inhibitor of KDR tyrosine kinase activity, efficiently blocks oncogenic RET kinases.ZD6474是一种口服可用的KDR酪氨酸激酶活性抑制剂,能有效阻断致癌性RET激酶。
Cancer Res. 2002 Dec 15;62(24):7284-90.
7
Enhancement of activation-induced apoptosis of lymphocytes by the cytotoxic ribonuclease onconase (Ranpirnase).细胞毒性核糖核酸酶昂卡司他(兰吡奈酶)增强激活诱导的淋巴细胞凋亡
Int J Oncol. 2002 Dec;21(6):1245-50. doi: 10.3892/ijo.21.6.1245.
8
Transcriptionally targeted retroviral vector for combined suicide and immunomodulating gene therapy of thyroid cancer.
J Clin Endocrinol Metab. 2002 Nov;87(11):5304-11. doi: 10.1210/jc.2002-020975.
9
DNA and its associated processes as targets for cancer therapy.作为癌症治疗靶点的DNA及其相关过程。
Nat Rev Cancer. 2002 Mar;2(3):188-200. doi: 10.1038/nrc749.
10
Essential stations in the intracellular pathway of cytotoxic bovine seminal ribonuclease.细胞毒性牛精核糖核酸酶细胞内途径中的关键位点。
Biochem J. 2002 Mar 15;362(Pt 3):553-60. doi: 10.1042/0264-6021:3620553.